• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Analysis and interpretation of response rates for anticancer drugs.

作者信息

Lee Y J, Catane R, Rozencweig M, Bono V H, Muggia F M, Simon R, Staquet M J

出版信息

Cancer Treat Rep. 1979 Nov-Dec;63(11-12):1713-20.

PMID:526909
Abstract

A statistical method for interpreting data on the efficacy of anticancer agents is proposed. Tables were prepared for the retrospective analysis of studies evaluating the activity of anticancer agents against individual tumor types. The number of responding patients and the number of patients entered in the study were used to more objectively and formally determine the future disposition of the drug. Several examples of clinical studies show that use of our tables allows a more satisfactory and reliable classification than is often currently reported.

摘要

相似文献

1
Analysis and interpretation of response rates for anticancer drugs.
Cancer Treat Rep. 1979 Nov-Dec;63(11-12):1713-20.
2
Two-stage plans for patient accrual in phase II cancer clinical trials.II期癌症临床试验中患者入组的两阶段计划。
Cancer Treat Rep. 1979 Nov-Dec;63(11-12):1721-6.
3
Strategy for the development of novel anticancer drugs.新型抗癌药物的研发策略。
Cancer Chemother Pharmacol. 2003 Jul;52 Suppl 1:S97-101. doi: 10.1007/s00280-003-0596-x. Epub 2003 Jun 18.
4
How large should a phase II trial of a new drug be?一种新药的II期试验应该有多大规模?
Cancer Treat Rep. 1987 Nov;71(11):1079-85.
5
[Phase II clinical trial of anticancer drugs].
Gan To Kagaku Ryoho. 1991 Jul;18(9):1493-8.
6
Whatever happened to NSC--? An analysis of clinical results of discontinued anticancer agents.
Cancer Treat Rep. 1977 Aug;61(5):759-68.
7
A statistical simulation study finds discordance between WHO criteria and RECIST guideline.一项统计模拟研究发现,世界卫生组织(WHO)标准与实体瘤疗效评价标准(RECIST)指南之间存在不一致。
J Clin Epidemiol. 2004 Apr;57(4):358-65. doi: 10.1016/j.jclinepi.2003.07.015.
8
A statistical model for predicting response of breast cancer patients to cytotoxic chemotherapy.一种预测乳腺癌患者对细胞毒性化疗反应的统计模型。
Cancer Res. 1978 Aug;38(8):2544-8.
9
[Analysis of factors affecting clinical cancer chemotherapy].[影响临床癌症化疗的因素分析]
Gan No Rinsho. 1983 Aug;29(10):1199-204.
10
Therapeutic response in phase I trials of antineoplastic agents.抗肿瘤药物一期试验中的治疗反应。
Cancer Treat Rep. 1986 Sep;70(9):1105-15.

引用本文的文献

1
VP16-213 (etoposide). A critical review of its activity.依托泊苷(VP16 - 213)。对其活性的批判性综述。
Cancer Chemother Pharmacol. 1982;7(2-3):81-5. doi: 10.1007/BF00254526.
2
Etoposide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in combination chemotherapy of cancer.依托泊苷。对其药效学和药代动力学特性以及在癌症联合化疗中的治疗潜力的综述。
Drugs. 1990 Mar;39(3):438-90. doi: 10.2165/00003495-199039030-00008.
3
Neuro-oncology index and review (adult primary brain tumors). Radiotherapy, chemotherapy, immunotherapy, photodynamic therapy.
神经肿瘤学索引与综述(成人原发性脑肿瘤)。放射治疗、化学疗法、免疫疗法、光动力疗法。
J Neurooncol. 1991 Oct;11(2):85-147. doi: 10.1007/BF02390173.